Postoperative insomnia and follicle-stimulating hormone (FSH) levels are independent risk factors for CPSP at 3 and 6-month postoperatively, with postoperative insomnia increasing risk and higher FSH levels exerting a protective effect. The gene discussed is BRD2; the disease is insomnia measurement.